Previous Close | 4.9400 |
Open | 4.9400 |
Bid | 4.8500 x 1200 |
Ask | 4.9000 x 1000 |
Day's Range | 4.7900 - 4.9400 |
52 Week Range | 3.7300 - 8.8800 |
Volume | 25,896 |
Avg. Volume | 485,259 |
Market Cap | 44.259M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
JUPITER, FL / ACCESSWIRE / March 11, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a CBD-based pharmaceuticals company with 4 significant treatments in skin health for eczema, skin cancer, burns and herpes is pleased to announce that SRM Entertainment is on track for the month of March to produce its highest monthly sales since the wholly owned subsidiary was acquired in December of 2020.
Ecommerce site is expanded and optimized for Company's growing portfolio of CBD wellness products JUPITER, FL / ACCESSWIRE / March 2, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a CBD-based pharmaceuticals company with 4 significant treatments in skin health for eczema, skin cancer, burns and herpes is pleased to announce the launch of their new e-commerce website.
JW-100 cleared or reduced eczema following 2 weeks of use in half of the subjects in the JW-100 arm of the randomized placebo-controlled study50% of subjects in the JW-100 arm achieved ISGA clear or almost clear (1 or 2) with at least a 2-grade . * JW-100 cleared or reduced eczema following 2 weeks of use in half of the subjects in the JW-100 arm of the randomized placebo-controlled study * 50% of subjects in the JW-100 arm achieved ISGA clear or almost clear (1 or 2) with at least a 2-grade improvement from baseline after treatment versus 20% and 15% in the CBD-only and placebo arms * Jupiter plans to file IND with the U.